Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tonix Pharmaceuticals

13.63
+0.16001.19%
Pre-market: 14.000.3700+2.71%08:23 EDT
Volume:777.82K
Turnover:10.27M
Market Cap:76.20M
PE:-1.76
High:13.67
Open:13.53
Low:12.35
Close:13.47
Loading ...

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)

GlobeNewswire
·
16 Oct 2024

Noble Financial Sticks to Its Buy Rating for Tonix Pharma (TNXP)

TIPRANKS
·
13 Oct 2024

Tonix Pharma Enhances Drug Development with AI Partnership

TipRanks
·
09 Oct 2024

Tonix Pharmaceuticals announces AI collaboration with X-Chem

TIPRANKS
·
08 Oct 2024

Tonix Pharmaceuticals Announces AI Collaboration With X-Chem to Develop Broad-Spectrum Antivirals

THOMSON REUTERS
·
08 Oct 2024

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals

GlobeNewswire
·
08 Oct 2024

BRIEF-Tonix Pharmaceuticals Entered Into An AI And ML Research Collaboration With X-Chem

Reuters
·
08 Oct 2024

Tonix Pharmaceuticals: Entered Into an AI and Ml Research Collaboration With X-Chem, Inc

THOMSON REUTERS
·
08 Oct 2024

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

ACCESSWIRE
·
01 Oct 2024

Tonix Pharmaceuticals (TNXP) Has a Promising Pipeline but Faces Financial Challenges

TIPRANKS
·
01 Oct 2024

Tonix Pharmaceuticals participates in Endpoints panel at RECOVER workshop

TIPRANKS
·
30 Sep 2024

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID)

GlobeNewswire
·
30 Sep 2024

Tonix Pharmaceuticals Receives US Patent for Migraine Treatment; Shares Rise

MT Newswires Live
·
27 Sep 2024

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® Symtouch® to Treat Migraines

THOMSON REUTERS
·
27 Sep 2024

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines

GlobeNewswire
·
27 Sep 2024

BRIEF-Tonix Pharmaceuticals Holding Corp Files For Mixed Shelf Offering Of Upto $300 Million- SEC Filing

Reuters
·
21 Sep 2024